MoneyWorks4Me

Vivo Bio Tech - Quaterly Results

19 May 2025 Evaluate
The revenue for the March 2025 quarter is pegged at Rs. 122.91 millions, about 6.42% up against Rs. 115.50 millions recorded during the year-ago period.Profit after tax for the quarter ended March 2025 reported a huge growth of 70.16% to Rs. 11.86  millions from Rs. 6.97 millions.Operating profit for the quarter ended March 2025 decreased to 52.92 millions as compared to 53.38 millions of corresponding quarter ended March 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 122.91 115.50 6.42 466.72 448.81 3.99 466.72 448.81 3.99
Other Income 1.53 0.09 1600.00 48.05 0.39 12220.51 48.05 0.39 12220.51
PBIDT 52.92 53.38 -0.86 256.01 211.23 21.20 256.01 211.23 21.20
Interest 16.81 15.18 10.74 75.04 77.78 -3.52 75.04 77.78 -3.52
PBDT 36.11 38.20 -5.47 180.97 133.45 35.61 180.97 133.45 35.61
Depreciation 22.46 24.26 -7.42 90.17 92.91 -2.95 90.17 92.91 -2.95
PBT 13.65 13.94 -2.08 90.80 40.54 123.98 90.80 40.54 123.98
TAX 1.79 6.97 -74.32 15.11 15.32 -1.37 15.11 15.32 -1.37
Deferred Tax -3.10 -0.32 868.75 -5.72 -1.43 300.00 -5.72 -1.43 300.00
PAT 11.86 6.97 70.16 75.69 25.22 200.12 75.69 25.22 200.12
Equity 171.65 149.04 15.17 171.65 149.04 15.17 171.65 149.04 15.17
PBIDTM(%) 43.06 46.22 -6.84 54.85 47.06 16.55 54.85 47.06 16.55
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..